Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Zuberbier

Showing results (291-300 of 423) with videos related to

Pageof 43
Sort By:
Allergy|December 30, 2020
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position PaperLudger Klimek, Marek Jutel, Cezmi A Akdis, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 3, 2021
A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforceSophia Tsabouri, Stefania Arasi, Burcin Beken, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 25, 2025
An overview on current practices regarding the diagnosis and management of chronic urticaria in pediatrics: An EAACI Task Force reportStefania Arasi, Helena Pite, Burcin Beken, et al.
Clinical and Translational Allergy|December 9, 2020
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategiesJean Bousquet, Jean-Paul Cristol, Wienczyslawa Czarlewski, et al.
Allergologie Select|July 26, 2024
Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelinesRafael José Vieira, Maria Inês Torres, Antonio Bognanni, et al.
Allergo Journal International|June 30, 2015
Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)Knut Brockow, Bernhard Przybilla, Werner Aberer, et al.
The World Allergy Organization Journal|January 11, 2021
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical casesJean Bousquet, Vincent Le Moing, Hubert Blain, et al.
Allergologie Select|June 5, 2024
"Delabeling" by direct provocation testing in children and adolescents with a suspected history of a delayed reaction to β-lactam antibiotics: Consensus paper of Gesellschaft für pädiatrische Allergologie und Umweltmedizin (GPAU), Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI), and Ärzteverband deutscher Allergologen (ÄDA)Irena Neustädter, Sophie Blatt, Gerda Wurpts, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 4, 2021
The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI PerspectiveJean Bousquet, Marek Jutel, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseMarcus Maurer, Sabine Altrichter, Thomas Bieber, et al.
Pageof 43

Showing results (291-300 of 423) with videos related to

Sort By:
Pageof 43
Allergy|December 30, 2020
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position PaperLudger Klimek, Marek Jutel, Cezmi A Akdis, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 3, 2021
A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforceSophia Tsabouri, Stefania Arasi, Burcin Beken, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 25, 2025
An overview on current practices regarding the diagnosis and management of chronic urticaria in pediatrics: An EAACI Task Force reportStefania Arasi, Helena Pite, Burcin Beken, et al.
Clinical and Translational Allergy|December 9, 2020
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategiesJean Bousquet, Jean-Paul Cristol, Wienczyslawa Czarlewski, et al.
Allergologie Select|July 26, 2024
Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelinesRafael José Vieira, Maria Inês Torres, Antonio Bognanni, et al.
Allergo Journal International|June 30, 2015
Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)Knut Brockow, Bernhard Przybilla, Werner Aberer, et al.
The World Allergy Organization Journal|January 11, 2021
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical casesJean Bousquet, Vincent Le Moing, Hubert Blain, et al.
Allergologie Select|June 5, 2024
"Delabeling" by direct provocation testing in children and adolescents with a suspected history of a delayed reaction to β-lactam antibiotics: Consensus paper of Gesellschaft für pädiatrische Allergologie und Umweltmedizin (GPAU), Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI), and Ärzteverband deutscher Allergologen (ÄDA)Irena Neustädter, Sophie Blatt, Gerda Wurpts, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 4, 2021
The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI PerspectiveJean Bousquet, Marek Jutel, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseMarcus Maurer, Sabine Altrichter, Thomas Bieber, et al.
Pageof 43